Baird Financial Group
ORIC icon

Baird Financial Group’s Oric Pharmaceuticals ORIC Stock Holding History

Baird Financial Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,691
Closed -$87.6K – 1831
2025
Q1 		$87.6K Hold
15,691
– – ﹤0.01% 1725
2024
Q4 		$127K Hold
15,691
– – ﹤0.01% 1707
2024
Q3 		$161K Buy
15,691
+2,700
+21% +$26.7K ﹤0.01% 1673
2024
Q2 		$91.8K Buy
12,991
+650
+5% +$5.82K ﹤0.01% 1724
2024
Q1 		$170K Hold
12,341
– – ﹤0.01% 1690
2023
Q4 		$114K Buy
+12,341
New +$89.2K ﹤0.01% 1674

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return